Figure 5.

Drug Survival and Reasons for Therapy Discontinuation for Treatment Groups as monotherapy. Comparison of several immunosuppressants for drug survival (A), cumulative incidence reasons for therapy discontinuation of higher‐dose steroids (B), lower‐dose steroids (C), azathioprine (D), mycophenolate mofetil (E), tacrolimus (F), and rituximab (G). The most frequent reason for treatment stoppage of lower‐dose steroids, azathioprine, and mycophenolate mofetil was disease breakthrough; the most common reason for cessation of tacrolimus and rituximab was adverse events. AZA, azathioprine; MMF, mycophenolate mofetil; TAC, tacrolimus; RTX, rituximab